Whoop

Consumer Health | Wearables | Health Technology | Subscription Software

toronto, Canada

Whoop
Consumer Services
Secondary
Revenue: $10M or More
Verified shareholder
$ 9
$ 8,000,000,000
Angel investor
Common shares
<0.01%
The US$9 PPS and US$8B valuation are opportunity terms supplied to us, not independently verified company pricing. Confirm the share class, fully diluted share count, seller ownership and whether the price is on the same basis as the Series G preferred shares.
Introductions only. Any transfer is subject to company consent and existing investors' rights of first refusal.
Make an Offer

Summary

WHOOP is a wearable technology company that combines a screenless sensor with a mobile application and paid membership.

Unlike conventional smartwatches, WHOOP focuses on continuous physiological monitoring rather than notifications, calls or displaying information on a screen.

Its value proposition is simple: help users understand how their body responds to exercise, sleep, stress, nutrition and everyday behaviour.

The platform uses biometric data and personalised analytics to recommend when users should train harder, recover or adjust their lifestyle. 

The Business

A. WHOOP 5.0

Screenless wearable that continuously tracks heart rate, heart-rate variability, sleep, respiratory rate, activity and other physiological metrics.

B. WHOOP MG

Medical-grade hardware with additional health features, including ECG readings and irregular heart rhythm notifications where available.

C. WHOOP App and AI Coach

Provides personalised coaching, sleep and recovery scores, strain analysis, stress monitoring, health trends and behaviour insights.

D. WHOOP Advanced Labs

Adds blood testing and health insights to the wearable platform, extending the business beyond daily fitness monitoring.

E. WHOOP Unite

Business and organisational offering for corporate wellness, teams and health-focused organisations.

Whoop Support+2

5. Membership model and pricing

WHOOP follows a subscription-led model. Hardware is bundled with a membership, creating recurring revenue and an ongoing relationship with the customer.

Membership

US annual price

Main features

WHOOP One

US$199

Sleep, strain, recovery and core fitness insights

WHOOP Peak

US$239

Additional health monitoring, stress and Healthspan

WHOOP Life

US$359

Medical-grade hardware, ECG and additional health features

Prices and feature availability vary by region and membership terms.

Whoop Support+1

Why this model matters: Unlike a one-time hardware sale, membership renewals can generate recurring revenue, improve customer lifetime value and create opportunities to sell additional health services.

6. Market opportunity

Market

Opportunity

Fitness wearables

Continuous tracking of exercise and activity

Preventive health

Early identification of changes in health metrics

Sleep technology

Sleep quality, duration and recovery insights

Corporate wellness

Health and performance monitoring for organisations

Sports performance

Training optimisation and athlete recovery

Digital health

Personalised insights using longitudinal biometric data

Diagnostics

Integration of blood testing and clinical services

Market drivers

  • Rising consumer focus on health and longevity.

  • Growing adoption of wearable health devices.

  • Demand for personalised fitness and wellness recommendations.

  • Increasing use of AI to interpret health data.

  • Shift from reactive healthcare towards preventive monitoring.

7. Customers, partnerships and ecosystem

WHOOP has built a strong brand among athletes, fitness enthusiasts and health-conscious consumers.

Notable strategic relationships include:

  • Abbott — strategic investor and healthcare technology partner.

  • Mayo Clinic — investor in the Series G round, bringing clinical and healthcare expertise.

  • Quest Diagnostics — blood-testing ecosystem associated with WHOOP Advanced Labs.

  • GRAIL — partnership ecosystem for advanced cancer screening access.

  • HealthEx — health-record connectivity.

  • Athlete investors and ambassadors — including Cristiano Ronaldo, LeBron James and Rory McIlroy.

These relationships support WHOOP's positioning as a broader health platform, rather than simply a fitness tracker manufacturer.

WHOOP+2

8. Financial information

WHOOP does not publicly disclose a complete set of audited financial statements. Its March 2026 funding announcement provides useful operating indicators.Disclosed operating indicators

Indicator

Reported figure

Global members

2.5M+

2025 bookings growth

103% YoY

2025 exit bookings run rate

US$1.1B

2025 cash flow

Cash-flow positive

Physiological data processed

24B+ hours

Planned global hiring in 2026

600+ roles

WHOOP+1

Financial interpretation: The US$1.1B figure is a bookings run rate, not necessarily recognised revenue or ARR. It should not be inserted as reported revenue in a financial model without a reconciliation. EBITDA, gross margin and CAPEX remain undisclosed.

The Market

Funding and valuation history

Date

Round

Amount

Valuation

October 2020

Series E

US$100M

US$1.2B

August 2021

Series F

~US$200M

US$3.6B

March 2026

Series G

US$575M

US$10.1B

The Series G round was led by Collaborative Fund, with participation from QIA, Mubadala, Abbott, Mayo Clinic, Macquarie Capital, IVP and other institutional and individual investors.

WHOOP+2

The latest publicly announced financing valuation of US$10.1B provides the primary valuation benchmark for evaluating the offered US$8B secondary opportunity.

Financial Data

Financials Last 12 Months
Revenue $0
Data provided by the founder.

Growth Roadmap

  1. International expansion: Grow membership across Europe, the GCC, Latin America and Asia.

  2. Medical and health features: Expand the product from fitness tracking into broader health monitoring.

  3. AI-powered coaching: Use accumulated biometric data to improve personalised recommendations.

  4. Advanced diagnostics: Expand blood testing and clinical service integrations.

  5. Enterprise growth: Develop WHOOP Unite for corporate and organisational customers.

  6. Health platform strategy: Build a unified platform connecting wearable data, diagnostics and health records.

WHOOP's stated Series G strategy includes global expansion, product development and investment in its personalised health platform.

WHOOP+1

11. Competitive landscape

Competitor

Positioning

Oura

Smart rings focused on sleep, recovery and health

Apple

Apple Watch health and fitness ecosystem

Garmin

Sports, fitness and performance wearables

Fitbit

Consumer fitness and health tracking

Samsung

Galaxy Watch and health monitoring

Ultrahuman

Smart rings and metabolic health monitoring

WHOOP's differentiation

  • Screenless, distraction-free design.

  • Strong focus on recovery, sleep and physiological performance.

  • Subscription-based business model.

  • Personalised coaching and longitudinal biometric data.

  • Premium positioning among athletes and health-conscious consumers.

12. Additional transaction information — internal use

Entry valuation analysis

Indicative secondary valuation

US$8.0B

Latest Series G valuation

US$10.1B

Indicative discount

20.8%

Offered PPS

US$9.00

Illustrative comparison, assuming equivalent share rights and capitalisation.

Fee economics

The opportunity is quoted as 5 / 0 / 0.

If the first 5% is a transaction fee charged on the investment amount:

Investment

Illustrative 5% fee

US$250K

US$12,500

US$500K

US$25,000

US$1M

US$50,000

US$2M

US$100,000

US$5M

US$250,000

Fee payer, calculation base and whether the fee is added to the US$9 PPS must be confirmed before quoting all-in investor pricing.

13. Key investment positives and risks

Positives

  • Established global wearable brand.

  • 2.5M+ members and strong subscription growth.

  • Cash-flow-positive operations reported for 2025.

  • US$1.1B bookings run rate at the end of 2025.

  • Strong institutional and strategic investor participation.

  • Expansion into diagnostics, preventive health and AI-driven insights.

  • Potential secondary entry below the latest disclosed financing valuation.

Risks

  • US$8B is still a substantial valuation.

  • Hardware manufacturing, inventory and supply-chain exposure.

  • Subscription churn and customer acquisition costs.

  • Competition from Apple, Oura and Garmin.

  • Medical-feature regulatory and product-claim risks.

  • Limited publicly available audited financial information.

  • Share transfer restrictions and potential illiquidity before an IPO.

Uploaded Documents

No documents uploaded

$ 9
$ 8,000,000,000
Angel investor
Common shares
<0.01%
The US$9 PPS and US$8B valuation are opportunity terms supplied to us, not independently verified company pricing. Confirm the share class, fully diluted share count, seller ownership and whether the price is on the same basis as the Series G preferred shares.
Introductions only. Any transfer is subject to company consent and existing investors' rights of first refusal.
Make an Offer